Regeneron created a monoclonal antibody for Covid by using stem cells. They couldn’t use the cloning process that Bioclonetics has a patent for. So it’s a similar way of creating antibodies but is not the same. Bioclonetics is further along in their study for HIV only, they have not started COVID trials but are waiting CDC approval. So no one can do the cloning process unless they get licensing rights from Bioclonetics. Or, they buy them out.
News 
Market Data 
Discover 
